These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22972444)

  • 1. Quality of life and patient-perceived difficulties in the treatment of type 2 diabetes.
    Tamir O; Wainstein J; Raz I; Shemer J; Heymann A
    Rev Diabet Stud; 2012; 9(1):46-54. PubMed ID: 22972444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of perception of insulin therapy among Chinese patients with type 2 diabetes mellitus.
    Chen CC; Chang MP; Hsieh MH; Huang CY; Liao LN; Li TC
    Diabetes Metab; 2011 Nov; 37(5):389-94. PubMed ID: 21458350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics Predictive for a Successful Switch from Insulin Analogue Therapy to Oral Hypoglycemic Agents in Patients with Type 2 Diabetes.
    Kim G; Lee YH; Kang ES; Cha BS; Lee HC; Lee BW
    Yonsei Med J; 2016 Nov; 57(6):1395-403. PubMed ID: 27593867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delay of insulin initiation in patients with type 2 diabetes mellitus inadequately controlled with oral hypoglycemic agents (analysis of patient- and physician-related factors): A prospective observational DIPP-FACTOR study in Korea.
    Kim SG; Kim NH; Ku BJ; Shon HS; Kim DM; Park TS; Kim YS; Kim IJ; Choi DS
    J Diabetes Investig; 2017 May; 8(3):346-353. PubMed ID: 27712034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects on All-cause Mortality and Cardiovascular Outcomes in Patients With Type 2 Diabetes by Comparing Insulin With Oral Hypoglycemic Agent Therapy: A Meta-analysis of Randomized Controlled Trials.
    Li J; Tong Y; Zhang Y; Tang L; Lv Q; Zhang F; Hu R; Tong N
    Clin Ther; 2016 Feb; 38(2):372-386.e6. PubMed ID: 26774276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: the role of once-daily insulin glargine.
    Bradley C; Gilbride CJ
    Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():50-65. PubMed ID: 18577157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S; Estacio RO; Jeffers B; Schrier RW
    Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of insulin-oral hypoglycemic agents combined therapy in outpatients with type 2 diabetes.
    Sinagra D; Scarpitta AM; Amato M
    Eur Rev Med Pharmacol Sci; 1998; 2(5-6):175-9. PubMed ID: 10710815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the Omnipod
    Polonsky WH; Hessler D; Layne JE; Zisser H
    Diabetes Technol Ther; 2016 Oct; 18(10):664-670. PubMed ID: 27673352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the use of anti-diabetic drugs on survival of diabetic dialysis patients: a 5-year retrospective cohort study in Taiwan.
    Hsiao PJ; Wu KL; Chiu SH; Chan JS; Lin YF; Wu CZ; Wu CC; Kao S; Fang TC; Lin SH; Chen JS
    Clin Exp Nephrol; 2017 Aug; 21(4):694-704. PubMed ID: 27599981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents.
    Kalsekar ID; Madhavan SS; Amonkar MM; Makela EH; Scott VG; Douglas SM; Elswick BL
    Ann Pharmacother; 2006 Apr; 40(4):605-11. PubMed ID: 16551768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bedtime intermediate-acting insulin in the treatment of secondary failure to oral hypoglycemic agents.
    Chuang LM; Lu C; Su RJ; Wu HP; Tai TY; Lin BJ
    J Formos Med Assoc; 1992 Feb; 91(2):185-9. PubMed ID: 1364216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of insulin therapy on quality of life in Type 2 diabetes mellitus: The Fremantle Diabetes Study.
    Davis TM; Clifford RM; Davis WA;
    Diabetes Res Clin Pract; 2001 Apr; 52(1):63-71. PubMed ID: 11182217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
    Braun A; Sämann A; Kubiak T; Zieschang T; Kloos C; Müller UA; Oster P; Wolf G; Schiel R
    Patient Educ Couns; 2008 Oct; 73(1):50-9. PubMed ID: 18583087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of patient-reported outcome instruments measuring health-related quality of life and satisfaction in patients with type 2 diabetes treated with oral therapy.
    Roborel de Climens A; Tunceli K; Arnould B; Germain N; Iglay K; Norquist J; Brodovicz KG
    Curr Med Res Opin; 2015 Apr; 31(4):643-65. PubMed ID: 25708743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient reported outcomes in adults with type 2 diabetes on basal insulin randomized to addition of mealtime pramlintide or rapid-acting insulin analogs.
    Peyrot M; Rubin RR; Polonsky WH; Best JH
    Curr Med Res Opin; 2010 May; 26(5):1047-54. PubMed ID: 20199136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of combination therapy with insulin and oral hypoglycemic agents in patients with type II diabetes during a 1-year period.
    Mozersky RP; Patel H; Bahl VK; Bahl S; Mook W
    J Am Osteopath Assoc; 1996 Jun; 96(6):346-51. PubMed ID: 8690621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life as a key indicator of patient satisfaction and treatment compliance in people with type 2 diabetes mellitus in the IMPROVE study: a multicentre, open label, non-randomised, observational trial.
    Mukherjee AK; Reddy VS; Shah S; Jhingan AK; Ramakrishnan P; Prusty V; Singh NS
    J Indian Med Assoc; 2009 Jul; 107(7):464-70. PubMed ID: 20112854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence of patients with type 2 diabetes mellitus to medications: the role of risk preferences.
    Simon-Tuval T; Shmueli A; Harman-Boehm I
    Curr Med Res Opin; 2018 Feb; 34(2):345-351. PubMed ID: 29069921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal study on glycaemic control and quality of life in patients with Type 2 diabetes mellitus referred for intensified control.
    Goddijn PP; Bilo HJ; Feskens EJ; Groeniert KH; van der Zee KI; Meyboom-de Jong B
    Diabet Med; 1999 Jan; 16(1):23-30. PubMed ID: 10229289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.